Literature DB >> 24482621

Prevention of surgical site infection in total joint arthroplasty: an international tertiary care center survey.

Benjamin F Ricciardi1, Mathias P Bostrom1, Lars Lidgren2, Jonas Ranstam3, Katharina M D Merollini4, Annette W-Dahl2.   

Abstract

BACKGROUND: Prevention strategies are critical to reduce infection rates in total joint arthroplasty (TJA), but evidence-based consensus guidelines on prevention of surgical site infection (SSI) remain heterogeneous and do not necessarily represent this particular patient population. QUESTIONS/PURPOSES: What infection prevention measures are recommended by consensus evidence-based guidelines for prevention of periprosthetic joint infection? How do these recommendations compare to expert consensus on infection prevention strategies from orthopedic surgeons from the largest international tertiary referral centers for TJA? PATIENTS AND METHODS: A review of consensus guidelines was undertaken as described by Merollini et al. Four clinical guidelines met inclusion criteria: Centers for Disease Control and Prevention's, British Orthopedic Association, National Institute of Clinical Excellence's, and National Health and Medical Research Council's (NHMRC). Twenty-eight recommendations from these guidelines were used to create an evidence-based survey of infection prevention strategies that was administered to 28 orthopedic surgeons from members of the International Society of Orthopedic Centers. The results between existing consensus guidelines and expert opinion were then compared.
RESULTS: Recommended strategies in the guidelines such as prophylactic antibiotics, preoperative skin preparation of patients and staff, and sterile surgical attire were considered critically or significantly important by the surveyed surgeons. Additional strategies such as ultraclean air/laminar flow, antibiotic cement, wound irrigation, and preoperative blood glucose control were also considered highly important by surveyed surgeons, but were not recommended or not uniformly addressed in existing guidelines on SSI prevention.
CONCLUSION: Current evidence-based guidelines are incomplete and evidence should be updated specifically to address patient needs undergoing TJA.

Entities:  

Keywords:  infection prevention strategies; international survey; prosthetic joint infection

Year:  2013        PMID: 24482621      PMCID: PMC3903952          DOI: 10.1007/s11420-013-9369-1

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  31 in total

1.  Practice guideline adherence and health care outcomes--use of prophylactic antibiotics during surgery in Taiwan.

Authors:  Chentong Hsu; Shou-Hsia Cheng
Journal:  J Eval Clin Pract       Date:  2009-12       Impact factor: 2.431

2.  Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study.

Authors:  F Y Chiu; C F Lin; C M Chen; W H Lo; T Y Chaung
Journal:  J Bone Joint Surg Br       Date:  2001-07

3.  Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection.

Authors:  Richard Iorio; Kelly M Williams; Andrew J Marcantonio; Lawrence M Specht; John F Tilzey; William L Healy
Journal:  J Arthroplasty       Date:  2011-11-04       Impact factor: 4.757

4.  Incidence, secular trends, and outcomes of prosthetic joint infection: a population-based study, olmsted county, Minnesota, 1969-2007.

Authors:  Geoffrey Tsaras; Douglas R Osmon; Tad Mabry; Brian Lahr; Jennifer St Sauveur; Barbara Yawn; Robert Kurland; Elie F Berbari
Journal:  Infect Control Hosp Epidemiol       Date:  2012-10-23       Impact factor: 3.254

5.  Increasing risk of revision due to deep infection after hip arthroplasty.

Authors:  Håvard Dale; Geir Hallan; Geir Hallan; Birgitte Espehaug; Leif I Havelin; Lars B Engesaeter
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

6.  Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009.

Authors:  Annette L Adams; Elizabeth W Paxton; Jean Q Wang; Eric S Johnson; Elizabeth A Bayliss; Assiamira Ferrara; Cynthia Nakasato; Stefano A Bini; Robert S Namba
Journal:  J Bone Joint Surg Am       Date:  2013-03-20       Impact factor: 5.284

7.  The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty.

Authors:  Milford H Marchant; Nicholas A Viens; Chad Cook; Thomas Parker Vail; Michael P Bolognesi
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

8.  Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees.

Authors:  Robert S Namba; Maria C S Inacio; Elizabeth W Paxton
Journal:  J Bone Joint Surg Am       Date:  2013-05-01       Impact factor: 5.284

9.  Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty.

Authors:  Justin S Cummins; Ivan M Tomek; Stephen R Kantor; Ove Furnes; Lars Birger Engesaeter; Samuel R G Finlayson
Journal:  J Bone Joint Surg Am       Date:  2009-03-01       Impact factor: 5.284

10.  Increasing risk of prosthetic joint infection after total hip arthroplasty.

Authors:  Håvard Dale; Anne M Fenstad; Geir Hallan; Leif I Havelin; Ove Furnes; Søren Overgaard; Alma B Pedersen; Johan Kärrholm; Göran Garellick; Pekka Pulkkinen; Antti Eskelinen; Keijo Mäkelä; Lars B Engesæter
Journal:  Acta Orthop       Date:  2012-10       Impact factor: 3.717

View more
  13 in total

Review 1.  Higher age, female gender, osteoarthritis and blood transfusion protect against periprosthetic joint infection in total hip or knee arthroplasties: a systematic review and meta-analysis.

Authors:  Vera Alice Correia Resende; Artur Costa Neto; Carla Nunes; Renato Andrade; João Espregueira-Mendes; Sílvia Lopes
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-11-09       Impact factor: 4.342

Review 2.  Indications and Guidelines for Debridement and Implant Retention for Periprosthetic Hip and Knee Infection.

Authors:  Douglas A Zaruta; Bowen Qiu; Andrew Y Liu; Benjamin F Ricciardi
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

3.  Sterile Parts of Operating Gown during Lower Limb Joint Replacement Surgery.

Authors:  Mohamad Qoreishi; Mohammadreza Abbasian; Farshad Safdari
Journal:  Arch Bone Jt Surg       Date:  2019-07

4.  Preoperative Sterilization Preparation of the Shoulder: A Comparative Study Evaluating Gauze Sponge and Commercially Available Applicator Prep Stick.

Authors:  Usman Ali M Syed; Adam J Seidl; Ryan A Hoffman; Justin Bianchini; Pedro K Beredjiklian; Joseph A Abboud
Journal:  Arch Bone Jt Surg       Date:  2018-01

5.  Decreased complication profile and improved clinical outcomes of primary reverse total shoulder arthroplasty after 2010: A systematic review.

Authors:  Raphael J Crum; Darren L de Sa; Favian L Su; Bryson P Lesniak; Albert Lin
Journal:  Shoulder Elbow       Date:  2019-06-19

6.  Effect of multidimensional intervention to reduce surgical site infection rate after knee and hip arthroplasty.

Authors:  Samar Saeed Morsi; Abeer Omar; Gautam Hebbar; Mariam Al-Fadhli; Wafaa S Hamza
Journal:  Germs       Date:  2021-03-15

7.  Nutritional status as a predictive marker for surgical site infection in total joint arthroplasty.

Authors:  Randa Alfargieny; Zuhir Bodalal; Riyad Bendardaf; Mustafa El-Fadli; Salem Langhi
Journal:  Avicenna J Med       Date:  2015 Oct-Dec

Review 8.  The Swedish Knee Arthroplasty Register: a review.

Authors:  O Robertsson; J Ranstam; M Sundberg; A W-Dahl; L Lidgren
Journal:  Bone Joint Res       Date:  2014-07       Impact factor: 5.853

9.  Risk of infection in primary, elective total hip arthroplasty with direct anterior approach or lateral transgluteal approach: a prospective cohort study of 1104 hips.

Authors:  Thomas Ilchmann; Werner Zimmerli; Lilianna Bolliger; Peter Graber; Martin Clauss
Journal:  BMC Musculoskelet Disord       Date:  2016-11-14       Impact factor: 2.362

10.  Consensus document on prosthetic joint infections.

Authors:  Stergios Lazarinis; Lars Lidgren; Anna Stefánsdóttir; Annette W-Dahl
Journal:  Acta Orthop       Date:  2013-11-29       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.